Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.
Atropos Health has raised $33.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
Atropos Health's investors include Gaingels, Samsung NEXT, Touchdown Ventures, Emerson Collective, Breyer Capital.
Atropos Health is headquartered in New York, United States.
Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.
Atropos Health is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atropos Health — Funding & Investors." VCBacked, May 23, 2024, https://www.vcbacked.co/company/atropos-health. Accessed July 20, 2026.
VCBacked. (2024). Atropos Health — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/atropos-health
{{cite web |title=Atropos Health — Funding & Investors |url=https://www.vcbacked.co/company/atropos-health |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated